Leonardo DRS director exercises 1,006 share units

Leonardo DRS, Inc. director Frances F. Townsend exercised restricted stock units into common shares as part of her equity compensation.

Rhea-AI Filing Summary

Leonardo DRS, Inc. director Frances F. Townsend exercised restricted stock units into common shares as part of her equity compensation. On June 30, 2026, 1,006 RSUs converted into 1,006 shares of common stock, with no open-market sale reported. Following the transaction, she directly holds 35,888 common shares and 2,013 RSUs.

The RSUs were granted on April 1, 2026 under the company’s 2022 Omnibus Equity Compensation Plan and vest quarterly. Vesting occurred on April 1 and June 30, 2026, with additional vesting scheduled for September 30 and December 31, 2026, conditioned on continued board service.

Insider Trade Summary

1,006 shares exercised/converted

Exercise 2 txns

Insider TOWNSEND FRANCES F

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	1,006	$0.00	$0.00
Exercise	Common Stock	1,006	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 2,013 contracts (Direct); Common Stock — 35,888 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of the Issuer.
2. F2. The RSUs were granted on April 1, 2026, under the Issuer's 2022 Omnibus Equity Compensation Plan. The RSUs vested quarterly on April 1, 2026 and June 30, 2026. The remaining RSUs will vest quarterly September 30, 2026 and December 31, 2026, subject to the Reporting Person's continued service as a member of the Issuer's Board of Directors through such date. The number of RSUs that vested on each of April 1, 2026 and June 30, 2026 and that will vest on September 30, 2026, shall be rounded down to the nearest whole number of RSUs and the remaining RSUs shall vest on December 31, 2026.

Key Figures

Shares acquired via RSU exercise: 1,006 shares Common shares after transaction: 35,888 shares RSUs remaining after transaction: 2,013 units +2 more

5 metrics

Shares acquired via RSU exercise 1,006 shares Common stock received from RSU conversion on June 30, 2026

Common shares after transaction 35,888 shares Direct Leonardo DRS holdings following June 30, 2026 transaction

RSUs remaining after transaction 2,013 units Restricted stock units still outstanding for Frances F. Townsend

RSU grant date April 1, 2026 Grant under 2022 Omnibus Equity Compensation Plan

Vesting schedule 2026 4 dates in 2026 RSUs vest on Apr 1, Jun 30, Sep 30, Dec 31, 2026

Key Terms

Restricted Stock Unit, contingent right, 2022 Omnibus Equity Compensation Plan, vested quarterly, +1 more

5 terms

Restricted Stock Unit financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of the Issuer."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

contingent right financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock..."

2022 Omnibus Equity Compensation Plan financial

"The RSUs were granted on April 1, 2026, under the Issuer's 2022 Omnibus Equity Compensation Plan."

vested quarterly financial

"The RSUs vested quarterly on April 1, 2026 and June 30, 2026."

Reporting Person financial

"...subject to the Reporting Person's continued service as a member of the Issuer's Board of Directors..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leonardo DRS (DRS) director Frances F. Townsend report in this Form 4?

Frances F. Townsend reported exercising 1,006 restricted stock units into 1,006 shares of Leonardo DRS common stock. This was a compensation-related derivative exercise, with no open-market purchases or sales disclosed in the filing.

How many Leonardo DRS (DRS) shares does Frances F. Townsend hold after the transaction?

After the June 30, 2026 transaction, Frances F. Townsend directly holds 35,888 shares of Leonardo DRS common stock. She also holds 2,013 restricted stock units that represent additional potential shares subject to future vesting conditions.

What are the key terms of the Leonardo DRS (DRS) restricted stock units reported?

Each restricted stock unit represents a contingent right to receive one Leonardo DRS common share. The RSUs were granted on April 1, 2026 under the 2022 Omnibus Equity Compensation Plan and vest in quarterly installments during 2026.

When do the Leonardo DRS (DRS) RSUs for Frances F. Townsend vest?

The RSUs granted to Frances F. Townsend vested on April 1 and June 30, 2026, and are scheduled to vest again on September 30 and December 31, 2026. Vesting depends on her continued service on the board through each vesting date.

Did Frances F. Townsend buy or sell Leonardo DRS (DRS) shares on the market?

The Form 4 shows a derivative exercise of restricted stock units, not an open-market trade. She acquired 1,006 common shares through RSU conversion, and the filing does not report any market purchases or sales on that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 07:37 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOWNSEND FRANCES F

(Last) (First) (Middle)

C/O LEONARDO DRS, INC.

2345 CRYSTAL DRIVE

(Street)

ARLINGTON VIRGINIA 22202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leonardo DRS, Inc. [ DRS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026		M		1,006	A	$0	35,888	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	06/30/2026		M			1,006	(2)	(2)	Common Stock	1,006	$0	2,013	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of the Issuer.

2. The RSUs were granted on April 1, 2026, under the Issuer's 2022 Omnibus Equity Compensation Plan. The RSUs vested quarterly on April 1, 2026 and June 30, 2026. The remaining RSUs will vest quarterly September 30, 2026 and December 31, 2026, subject to the Reporting Person's continued service as a member of the Issuer's Board of Directors through such date. The number of RSUs that vested on each of April 1, 2026 and June 30, 2026 and that will vest on September 30, 2026, shall be rounded down to the nearest whole number of RSUs and the remaining RSUs shall vest on December 31, 2026.

Remarks:

	/s/ Oriana D. Pietrangelo, Attorney-in-Fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)